Prostaglandin E2 and lipoxin A4 in PBMCs are associated with immune tolerance during venom immunotherapy

J Allergy Clin Immunol. 2016 Oct;138(4):1199-1202.e2. doi: 10.1016/j.jaci.2016.03.024. Epub 2016 Apr 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Desensitization, Immunologic*
  • Dinoprostone / blood*
  • Female
  • Humans
  • Immune Tolerance / physiology*
  • In Vitro Techniques
  • Insect Bites and Stings / immunology
  • Insect Bites and Stings / therapy
  • Interleukin-10 / blood
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism
  • Lipoxins / blood*
  • Male
  • Middle Aged
  • Transforming Growth Factor beta1 / blood
  • Wasp Venoms / immunology
  • Wasp Venoms / therapeutic use*
  • Wasps / immunology

Substances

  • IL10 protein, human
  • Lipoxins
  • Transforming Growth Factor beta1
  • Wasp Venoms
  • lipoxin A4
  • Interleukin-10
  • Dinoprostone